CLINICAL_TRIALS
trial_result
· 2011-08-01
Clinical Trial Update: Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma [Phase 4]
Summary
Phase 4 trial evaluating the effect of omalizumab on IgE receptor expression in adults with severe, inadequately controlled allergic asthma; results completed a…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2011-08-01